Abstracts

MPXV Replication Induces an IFN Response and Is Suppressed by IFN-γ

Background: Poxviruses have developed strategies to evade host antiviral immunity, particularly the Interferon (IFN) response, but limited data are available for Monkeypox virus (MPXV). To better understand how MPXV affects the IFN response, we analyzed type I, II and III IFNs and IFN stimulated genes (ISGs) expression in different MPXV-infected anatomical sites from male patients.…

10e8.4/iMAb Bispecific Antibody for Immunoprophylaxis Against High-Dose Intravenous SHIV Exposure

Background: A lead strategy for preventing HIV transmission is the passive provision of broadly neutralizing antibodies (bNAbs). Various investigators have validated this approach in nonhuman primate (NHP) models of HIV exposure. Experiments in NHPs have primarily focused on preventing viral transmission across anogenital mucosae. In humans, the antibody-mediated prevention (AMP) trial demonstrated that passively administered…

SARS-CoV-2 Natural Infection Elicits Cross-Reactive Immunity to OC43

Background: The recent SARS-CoV-2 pandemic renewed interest in other previously discovered non-severe acute respiratory syndrome human coronaviruses. Among these, OC43 is a seasonal human coronaviruses widely diffused in the global population (90% seroprevalence in adults), mostly responsible for mild respiratory symptoms. As OC43 protective immunity is short lasting the aim of this study was to…

SARS-CoV-2-Specific T-Cells Correlate With Airway Virus Control During Early Acute Infection

Background: SARS-CoV-2-specific T cell responses, including those targeting the Nucleocapsid (N) and the conserved Replication-Transcription Complex (RTC), have been associated with protection from infection and airway virus control. Methods: We studied the specificity and magnitude of SARS-CoV-2 T cell responses within the first week of symptom onset in previously unexposed individuals before seroconversion, using an…

ERAPs Control In Vitro and Ex Vivo SARS-CoV-2 Infection by Triggering Antiviral Immune Response

Background: ERAP1 and ERAP2 (ERAPs) are two endoplasmic reticulum aminopeptidases which control susceptibility/progression of different infectious diseases. Beyond their canonical role in antigen processing and presentation, following inflammatory stimuli ERAPs can be secreted and modulate both the acquired and natural immune response. We investigated in an in vitro model whether exogenous recombinant human (rh) ERAP…

Prior COVID-19 Alters Antibody Function in ART-Suppressed PWH Receiving SARS-CoV-2 Vaccination

Background: People with HIV infection (PWH) receiving suppressive antiretroviral therapy (ART) develop vaccine-driven immune responses (anti-RBD antibodies, RBD/ACE binding competition and neutralization) to early SARS-CoV-2 isolates similar to the general population. However, the impact of previous SARS-CoV-2 infection on the humoral and cellular immune response after a two-dose SARS-CoV-2 RNA vaccination in PWH on ART…

Immune Response to SARS-CoV-2 Omicron Breakthrough is a Recall of Vaccine-Induced Memory

Background: The COVID-19 vaccination campaign is considered the largest in history with over 70% of the global population having received at least one vaccine dose. While vaccination demonstrated outstanding results in cutting down the severity of the disease, breakthrough infections with the Omicron-derived variants occur frequently. Others and we have previously shown that vaccinated individuals…

Immune Responses to an Original/BA.4-5 Bivalent Booster of SARS-CoV-2 mRNA Vaccine in PWH on ART

Background: In the current Omicron era of COVID-19 pandemic, boosters with variant-adapted mRNA vaccines are recommended for fragile populations to provide broad protection against newly emergent SARS-CoV-2 variants. While previous studies showed enhanced neutralization against Omicron sub-lineages after a bivalent booster, data on T-cell immunity are limited, especially in PWH. We assessed humoral and T-cell…